mRNA expression levels of cytochrome P450 CYP1A2, CYP3A4, and CYP3A5 in the epidermis: a focus on individual differences among Japanese individuals

References

• Awortwe C, Manda VK, Avonto C, Khan SI, Khan IA, Walker LA, Bouic PJ, Rosenkranz B. 2015. Echinacea purpurea up-regulates CYP1A2, CYP3A4 and MDR1 gene expression by activation of pregnane X receptor pathway. Xenobiotica. 45(3):218–229. doi: 10.3109/00498254.2014.973930.
   PubMed Web of Science ®Google Scholar
• Baron JM, Höller D, Schiffer R, Frankenberg S, Neis M, Merk HF, Jugert FK. 2001. Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol. 116(4):541–548. doi: 10.1046/j.1523-1747.2001.01298.x.
   PubMed Web of Science ®Google Scholar
• Baron JM, Wiederholt T, Heise R, Merk HF, Bickers DR. 2008. Expression and function of cytochrome P450-dependent enzymes in human skin cells. Curr Med Chem. 15(22):2258–2264. doi: 10.2174/092986708785747535.
   PubMed Web of Science ®Google Scholar
• Brill MJ, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe CA. 2012. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 51(5):277–304. doi: 10.2165/11599410-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Brill MJ, van Rongen A, van Dongen EP, van Ramshorst B, Hazebroek EJ, Darwich AS, Rostami-Hodjegan A, Knibbe CA. 2015. The pharmacokinetics of the CYP3A substrate midazolam in morbidly obese patients before and one year after bariatric surgery. Pharm Res. 32(12):3927–3936. doi: 10.1007/s11095-015-1752-9.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Aleksunes LM, Manautou JE, Cherrington NJ, Scheffer GL, Yamasaki H, Slitt AL. 2008. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm. 5(1):77–91. doi: 10.1021/mp700114j.
   PubMedGoogle Scholar
• Choi SY, Kim MJ, Ahn GR, Park KY, Lee MK, Seo SJ. 2018. The effect of adiponectin on the regulation of filaggrin expression in normal human epidermal keratinocytes. Ann Dermatol. 30(6):645–652. doi: 10.5021/ad.2018.30.6.645.
   PubMed Web of Science ®Google Scholar
• Egi A, Sanuki M, Kinoshita H, Fujii K. 2001. Evaluation of adhesive tape containing lidocaine using current perception threshold measurement. Masui. 50(7):731–735. Japanese.
   PubMedGoogle Scholar
• Elentner A, Schmuth M, Yannoutsos N, Eichmann TO, Gruber R, Radner FPW, Hermann M, Del Frari B, Dubrac S. 2018. Epidermal overexpression of xenobiotic receptor PXR impairs the epidermal barrier and triggers Th2 immune response. J Invest Dermatol. 138(1):109–120. doi: 10.1016/j.jid.2017.07.846.
   PubMed Web of Science ®Google Scholar
• Feierman DE, Lasker JM. 1996. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos. 24(9):932–939.
   PubMed Web of Science ®Google Scholar
• Fukuen S, Fukuda T, Maune H, Ikenaga Y, Yamamoto I, Inaba T, Azuma J. 2002. Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population. Pharmacogenetics. 12(4):331–334. doi: 10.1097/00008571-200206000-00009.
   PubMedGoogle Scholar
• Guida B, Nino M, Perrino NR, Laccetti R, Trio R, Labella S, Balato N. 2010. The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venereol. 24(2):191–195. doi: 10.1111/j.1468-3083.2009.03503.x.
   PubMed Web of Science ®Google Scholar
• Hata S, Miki Y, Fujishima F, Sato R, Okaue A, Abe K, Ishida K, Akahira JI, Unno M, Sasano H. 2010. Cytochrome 3A and 2E1 in human liver tissue: individual variations among normal Japanese subjects. Life Sci. 86(11–12):393–401. doi: 10.1016/j.lfs.2010.01.011.
   PubMed Web of Science ®Google Scholar
• Hiratsuka M, Takekuma Y, Endo N, Narahara K, Hamdy SI, Kishikawa Y, Matsuura M, Agatsuma Y, Inoue T, Mizugaki M. 2002. Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population. Eur J Clin Pharmacol. 58(6):417–421. doi: 10.1007/s00228-002-0499-5.
   PubMed Web of Science ®Google Scholar
• Hirt PA, Castillo DE, Yosipovitch G, Keri JE. 2019. Skin changes in the obese patient. J Am Acad Dermatol. 81(5):1037–1057. doi: 10.1016/j.jaad.2018.12.070.
   PubMed Web of Science ®Google Scholar
• Hong SP, Seo HS, Shin KO, Park K, Park BC, Kim MH, Park M, Kim CD, Seo SJ. 2019. Adiponectin enhances human keratinocyte lipid synthesis via SIRT1 and nuclear hormone receptor signaling. J Invest Dermatol. 139(3):573–582. doi: 10.1016/j.jid.2018.08.032.
   PubMed Web of Science ®Google Scholar
• Horie Y, Makihara H, Horikawa K, Takeshige F, Ibuki A, Satake T, Yasumura K, Maegawa J, Mitsui H, Ohashi K, et al. 2018. Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes. PLOS One. 13(3):e0193830. doi: 10.1371/journal.pone.0193830.
   PubMed Web of Science ®Google Scholar
• Janmohamed A, Dolphin CT, Phillips IR, Shephard EA. 2001. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol. 62(6):777–786. doi: 10.1016/S0006-2952(01)00718-3.
   PubMed Web of Science ®Google Scholar
• Kao J, Carver MP. 1990. Cutaneous metabolism of xenobiotics. Drug Metab Rev. 22(4):363–410. doi: 10.3109/03602539009041089.
   PubMed Web of Science ®Google Scholar
• Kazem S, Linssen EC, Gibbs S. 2019. Skin metabolism phase I and phase II enzymes in native and reconstructed human skin: a short review. Drug Discov Today. 24(9):1899–1910. doi: 10.1016/j.drudis.2019.06.002.
   PubMed Web of Science ®Google Scholar
• Kuip EJ, Zandvliet ML, Koolen SL, Mathijssen RH, van der Rijt CC. 2017. A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. Br J Clin Pharmacol. 83(2):294–313. doi: 10.1111/bcp.13129.
   PubMed Web of Science ®Google Scholar
• Lukkari E, Taavitsainen P, Juhakoski A, Pelkonen O. 1998. Cytochrome P450 specificity of metabolism and interactions of oxybutynin in human liver microsomes. Pharmacol Toxicol. 82(4):161–166. doi: 10.1111/j.1600-0773.1998.tb01418.x.
   PubMedGoogle Scholar
• Lin YS, Dowling AL, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, Thummel KE. 2002. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol. 62(1):162–172. doi: 10.1124/mol.62.1.162.
   PubMed Web of Science ®Google Scholar
• Makihara H, Hidaka M, Sakai Y, Horie Y, Mitsui H, Ohashi K, Goshima Y, Akase T. 2017. Reduction and fragmentation of elastic fibers in the skin of obese mice is associated with altered mRNA expression levels of fibrillin-1 and neprilysin. Connect Tissue Res. 58(5):479–486. doi: 10.1080/03008207.2016.1255205.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Nakamura T. 1999. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 892(1):146–154. doi: 10.1111/j.1749-6632.1999.tb07793.x.
   PubMedGoogle Scholar
• Nakao M, Onji I. 1997. [The optimum time interval for applying lidocaine containing adhesive tape is 6 to 8 hours for venipuncture pain relief]. Masui. 46(10):1368–1373. Japanese.
   PubMedGoogle Scholar
• Oesch F, Fabian E, Guth K, Landsiedel R. 2014. Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models. Arch Toxicol. 88(12):2135–2190. doi: 10.1007/s00204-014-1382-8.
   PubMed Web of Science ®Google Scholar
• Oesch F, Fabian E, Landsiedel R. 2018. Correction to: xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models. Arch Toxicol. 92(11):3439–3439. doi: 10.1007/s00204-018-2301-1.
   PubMed Web of Science ®Google Scholar
• Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C, Landsiedel R. 2007. Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev. 39(4):659–698. doi: 10.1080/03602530701690366.
   PubMed Web of Science ®Google Scholar
• Ooi K. 2007. [Differences in pain anesthetic effect expression on using lidocaine tape for hemodialysis patients]. Yakugaku Zasshi. 127(11):1797–1799. Japanese. doi: 10.1248/yakushi.127.1797.
   PubMed Web of Science ®Google Scholar
• Orlando R, Piccoli P, De Martin S, Padrini R, Floreani M, Palatini P. 2004. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. Clin Pharmacol Ther. 75(1):80–88. doi: 10.1016/j.clpt.2003.09.007.
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Pichard-Garcia L, Daujat M, Fabre JM, Maurel P, Vilarem MJ. 2000. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun. 274(3):707–713. doi: 10.1006/bbrc.2000.3219.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Antona C, Donato MT, Pareja E, Gómez-Lechón MJ, Castell JV. 2001. Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch Biochem Biophys. 393(2):308–315. doi: 10.1006/abbi.2001.2499.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Morató J, Goday A, Langohr K, Pujadas M, Civit E, Pérez-Mañá C, Papaseit E, Ramon JM, Benaiges D, Castañer O, et al. 2019. Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity. Sci Rep. 9(1):20405. doi: 10.1038/s41598-019-57002-9.
   PubMedGoogle Scholar
• Smith G, Ibbotson SH, Comrie MM, Dawe RS, Bryden A, Ferguson J, Wolf CR. 2006. Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. Br J Dermatol. 155(2):275–281. doi: 10.1111/j.1365-2133.2006.07317.x.
   PubMed Web of Science ®Google Scholar
• Takenoshita-Nakaya S, Takeba Y, Ohta Y, Ootaki M, Watanabe M, Iiri T, Otsubo T, Kobayashi T, Machida T, Watanabe D, et al. 2018. Population profile of cytochrome P450 isozymes in the small intestine of Japanese. Jpn J Clin Pharmacol Ther. 49(1):3–6. doi: 10.3999/jscpt.49.3.
   Google Scholar
• Tomankova V, Anzenbacher P, Anzenbacherova E. 2017. Effects of obesity on liver cytochromes P450 in various animal models. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 161(2):144–151. doi: 10.5507/bp.2017.026.
   PubMed Web of Science ®Google Scholar
• Ulvestad M, Skottheim IB, Jakobsen GS, Bremer S, Molden E, Asberg A, Hjelmesæth J, Andersson TB, Sandbu R, Christensen H. 2013. Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects. Clin Pharmacol Ther. 93(3):275–282. doi: 10.1038/clpt.2012.261.
   PubMed Web of Science ®Google Scholar
• van Eijl S, Zhu Z, Cupitt J, Gierula M, Götz C, Fritsche E, Edwards RJ. 2012. Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling. PLOS One. 7(7):e41721. doi: 10.1371/journal.pone.0041721.
   PubMed Web of Science ®Google Scholar
• Westlind-Johnsson A, Malmebo S, Johansson A, Otter C, Andersson TB, Johansson I, Edwards RJ, Boobis AR, Ingelman-Sundberg M. 2003. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab Dispos. 31(6):755–761. doi: 10.1124/dmd.31.6.755.
   PubMed Web of Science ®Google Scholar
• Wang JS, Backman JT, Taavitsainen P, Neuvonen PJ, Kivistö KT. 2000. Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans. Drug Metab Dispos. 28(8):959–965.
   PubMed Web of Science ®Google Scholar
• Yaïch M, Popon M, Médard Y, Aigrain EJ. 1998. In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humans. Pharmacogenetics. 8(5):449–451. doi: 10.1097/00008571-199810000-00010.
   PubMedGoogle Scholar
• Yamaori S, Yamazaki H, Iwano S, Kiyotani K, Matsumura K, Saito T, Parkinson A, Nakagawa K, Kamataki T. 2005. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers. Xenobiotica. 35(1):69–83. doi: 10.1080/00498250400021796.
   PubMed Web of Science ®Google Scholar
• Yengi LG, Xiang Q, Pan J, Scatina J, Kao J, Ball SE, Fruncillo R, Ferron G, Roland Wolf CR. 2003. Quantitation of cytochrome P450 mRNA levels in human skin. Anal Biochem. 316(1):103–110. doi: 10.1016/S0003-2697(03)00042-3.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, DeVore A, Dawn A. 2007. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 56(6):901–916. quiz 917. doi: 10.1016/j.jaad.2006.12.004.
   PubMed Web of Science ®Google Scholar